Articles

Problems continue to add up for Lululemon, as the yoga-wear maker on Thursday trimmed its full-year forecast to account for a potential dip in sales this year.

Even upbeat Oracle earnings next week might not be enough to rally the market.

Innio’s stock soared in its debut, to outshine the shares of the more high-profile quantum-computing company, and Trump administration investment, Quantinuum.

A new legislative proposal would create a bipartisan commission to strengthen the finances of Social Security and Medicare at a time when the programs are under pressure.

Almost everything about this tax is bad, and it obscures something much better that we do need.

Want to buy SpaceX stock? History suggests it will struggle to reward IPO investors.

About 50 million Americans aren’t getting screened for colon cancer at a time when colon-cancer rates are rising.

While U.S. stocks have kept notching record highs, bitcoin is sliding to its weakest level in months.

The U.S. job market actually is getting a boost from AI: Who knew human workers are cheaper?

Social Security’s watchdog did the math on the so-called fraud, and it’s a joke.

The semiconductor trade is losing steam following Broadcom’s earnings report.

Netflix’s stock has dropped 24% since its last earnings report, with investors worried that competitive pressures may be weighing on growth.